Variable response to the diepoxybutane test in two dizygotic twins with Fanconi's anemia and flow cytometry for diagnosis confirmation

R. Toraldo, G. Canino, C. Tolone, M. D'Avanzo, B. Porfirio, H. Hoehn, T. Schroeder-Kurth, V. Pistoia

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Fanconi's anemia (FA) is a rare, genetically heterogeneous, autosomal recessive disorder characterized by bone marrow failure, congenital abnormalities, chromosome instability, and increased susceptibility to neoplasia. Congenital abnormalities vary in location and in severity, and not all patients are affected. Although the primary defect of FA is unknown, hypersensitivity to the clastogenic effect of agents that introduce cross- links in the DNA, such as diepoxybutane (DEB), is a marker of the FA phenotype in patients suffering from aplastic anemia without the physical characteristics of the syndrome and, conversely, in cases with abnormalities in the preanemic phase. We report the case of two dizygotic twins suffering from FA with discordant hematologic data. The DEB test repeated several times in various laboratories yielded conflicting results, whereas cell cycle studies by flow cytometry revealed a pattern typical of FA patients. Moreover, the flow cytometric pattern was correlated with the clinical severity of the disease.

Original languageEnglish
Pages (from-to)45-54
Number of pages10
JournalPediatric Hematology and Oncology
Volume15
Issue number1
Publication statusPublished - Jan 1998

Fingerprint

Fanconi Anemia
Dizygotic Twins
Flow cytometry
Chromosomes
Flow patterns
Flow Cytometry
Bone
DNA
Cells
Defects
Chromosomal Instability
Aplastic Anemia
Cell Cycle
Hypersensitivity
Bone Marrow
erythritol anhydride
Anemia
Phenotype
Neoplasms

Keywords

  • Diepoxybutane test (DEB test)
  • Fanconi's anemia
  • Flow cytometry

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology
  • Cancer Research
  • Management of Technology and Innovation

Cite this

Variable response to the diepoxybutane test in two dizygotic twins with Fanconi's anemia and flow cytometry for diagnosis confirmation. / Toraldo, R.; Canino, G.; Tolone, C.; D'Avanzo, M.; Porfirio, B.; Hoehn, H.; Schroeder-Kurth, T.; Pistoia, V.

In: Pediatric Hematology and Oncology, Vol. 15, No. 1, 01.1998, p. 45-54.

Research output: Contribution to journalArticle

Toraldo, R, Canino, G, Tolone, C, D'Avanzo, M, Porfirio, B, Hoehn, H, Schroeder-Kurth, T & Pistoia, V 1998, 'Variable response to the diepoxybutane test in two dizygotic twins with Fanconi's anemia and flow cytometry for diagnosis confirmation', Pediatric Hematology and Oncology, vol. 15, no. 1, pp. 45-54.
Toraldo, R. ; Canino, G. ; Tolone, C. ; D'Avanzo, M. ; Porfirio, B. ; Hoehn, H. ; Schroeder-Kurth, T. ; Pistoia, V. / Variable response to the diepoxybutane test in two dizygotic twins with Fanconi's anemia and flow cytometry for diagnosis confirmation. In: Pediatric Hematology and Oncology. 1998 ; Vol. 15, No. 1. pp. 45-54.
@article{9d8540ff968a4702a4b7129f3c47f9e0,
title = "Variable response to the diepoxybutane test in two dizygotic twins with Fanconi's anemia and flow cytometry for diagnosis confirmation",
abstract = "Fanconi's anemia (FA) is a rare, genetically heterogeneous, autosomal recessive disorder characterized by bone marrow failure, congenital abnormalities, chromosome instability, and increased susceptibility to neoplasia. Congenital abnormalities vary in location and in severity, and not all patients are affected. Although the primary defect of FA is unknown, hypersensitivity to the clastogenic effect of agents that introduce cross- links in the DNA, such as diepoxybutane (DEB), is a marker of the FA phenotype in patients suffering from aplastic anemia without the physical characteristics of the syndrome and, conversely, in cases with abnormalities in the preanemic phase. We report the case of two dizygotic twins suffering from FA with discordant hematologic data. The DEB test repeated several times in various laboratories yielded conflicting results, whereas cell cycle studies by flow cytometry revealed a pattern typical of FA patients. Moreover, the flow cytometric pattern was correlated with the clinical severity of the disease.",
keywords = "Diepoxybutane test (DEB test), Fanconi's anemia, Flow cytometry",
author = "R. Toraldo and G. Canino and C. Tolone and M. D'Avanzo and B. Porfirio and H. Hoehn and T. Schroeder-Kurth and V. Pistoia",
year = "1998",
month = "1",
language = "English",
volume = "15",
pages = "45--54",
journal = "Pediatric Hematology and Oncology",
issn = "0888-0018",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Variable response to the diepoxybutane test in two dizygotic twins with Fanconi's anemia and flow cytometry for diagnosis confirmation

AU - Toraldo, R.

AU - Canino, G.

AU - Tolone, C.

AU - D'Avanzo, M.

AU - Porfirio, B.

AU - Hoehn, H.

AU - Schroeder-Kurth, T.

AU - Pistoia, V.

PY - 1998/1

Y1 - 1998/1

N2 - Fanconi's anemia (FA) is a rare, genetically heterogeneous, autosomal recessive disorder characterized by bone marrow failure, congenital abnormalities, chromosome instability, and increased susceptibility to neoplasia. Congenital abnormalities vary in location and in severity, and not all patients are affected. Although the primary defect of FA is unknown, hypersensitivity to the clastogenic effect of agents that introduce cross- links in the DNA, such as diepoxybutane (DEB), is a marker of the FA phenotype in patients suffering from aplastic anemia without the physical characteristics of the syndrome and, conversely, in cases with abnormalities in the preanemic phase. We report the case of two dizygotic twins suffering from FA with discordant hematologic data. The DEB test repeated several times in various laboratories yielded conflicting results, whereas cell cycle studies by flow cytometry revealed a pattern typical of FA patients. Moreover, the flow cytometric pattern was correlated with the clinical severity of the disease.

AB - Fanconi's anemia (FA) is a rare, genetically heterogeneous, autosomal recessive disorder characterized by bone marrow failure, congenital abnormalities, chromosome instability, and increased susceptibility to neoplasia. Congenital abnormalities vary in location and in severity, and not all patients are affected. Although the primary defect of FA is unknown, hypersensitivity to the clastogenic effect of agents that introduce cross- links in the DNA, such as diepoxybutane (DEB), is a marker of the FA phenotype in patients suffering from aplastic anemia without the physical characteristics of the syndrome and, conversely, in cases with abnormalities in the preanemic phase. We report the case of two dizygotic twins suffering from FA with discordant hematologic data. The DEB test repeated several times in various laboratories yielded conflicting results, whereas cell cycle studies by flow cytometry revealed a pattern typical of FA patients. Moreover, the flow cytometric pattern was correlated with the clinical severity of the disease.

KW - Diepoxybutane test (DEB test)

KW - Fanconi's anemia

KW - Flow cytometry

UR - http://www.scopus.com/inward/record.url?scp=0031883844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031883844&partnerID=8YFLogxK

M3 - Article

C2 - 9509505

AN - SCOPUS:0031883844

VL - 15

SP - 45

EP - 54

JO - Pediatric Hematology and Oncology

JF - Pediatric Hematology and Oncology

SN - 0888-0018

IS - 1

ER -